# US 2020/0206391 A1 · Self-expanding devices and methods therefor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0206391 A1
- Document ID: US20200206391A1
- Status: Published application
- Kind: A1
- Application number: 16/727,345
- Filed: 2019-12-26
- Published: 2020-07-02
- Earliest claimed: 2007-12-18
- Assignees: Intersect ENT, Inc.
- Applicants: Intersect ENT, Inc.
- Inventors: Donald J. EATON; Bin HUANG; Anthony J. ABBATE; Gail M. ZALER; David C. GALE
- Web page: https://patentgrep.com/patent/US20200206391A1

## CPC

- A61L 31/022: {Metals or alloys}
- A61B 17/24: for use in the oral cavity, larynx, bronchial passages or nose (for medical inspection of cavities or tubes in the body A61B1/00); Tongue scrapers
- A61B 17/3468: {for implanting or removing devices, e.g. prostheses, implants, seeds, wires (devices for implanting seeds A61M37/0069)}
- A61B 17/3478: {Endoscopic needles, e.g. for infusion (biopsy needles A61B10/0233; catheters with injection needles A61M25/0067)}
- A61F 2/04: Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95)
- A61F 2/18: Internal ear or nose parts, e.g. ear-drums {(implants for middle ear ventilation or drainage A61F11/202)}
- A61F 2/82: Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07)
- A61F 2/86: Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F 2/89: the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
- A61F 2/95: Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F 5/08: Devices for correcting deformities of the nose {; Devices for enlarging the nostril, e.g. for breathing improvement}
- A61K 9/70: Web, sheet or filament bases {; Films; Fibres of the matrix type containing drug (hollow drug-filled fibres A61K9/0092)}
- A61L 31/10: Macromolecular materials
- A61L 31/148: {Materials at least partially resorbable by the body}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61M 29/00: Dilators with or without means for introducing media, e.g. remedies
- A61P 27/00: Drugs for disorders of the senses
- A61B 2017/3454: {Details of tips}
- A61F 2/186: {Nose parts}
- A61F 2/9522: {Means for mounting a stent or stent-graft onto or into a placement instrument}
- A61F 2/9524: {Iris-type crimpers}
- A61F 2002/048: {Ureters}
- A61F 2002/91508: {the meander having a difference in amplitude along the band}
- A61F 2210/0004: bioabsorbable
- A61F 2210/0076: multilayered, e.g. laminated structures
- A61F 2220/005: using adhesives
- A61F 2220/0058: soldered or brazed or welded
- A61F 2230/0091: helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
- A61F 2240/001: Designing or manufacturing processes
- A61F 2250/003: differing in adsorbability or resorbability, i.e. in adsorption or resorption time
- A61F 2250/006: modular
- A61F 2250/0067: Means for introducing or releasing pharmaceutical products into the body
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Described here are delivery devices for delivering one or more implants to the body, and methods of using. The delivery devices may deliver implants to a variety of locations within the body, for a number of different uses. In some variations, the delivery devices have a cannula with one or more curved sections. In some variations, a pusher may be used to release one or more implants from the cannula. In some variations, one or more of the released implants may be a self-expanding device. Methods of delivering implants to one or more sinus cavities are also described here.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A method of treating one or more urinary conditions in a patient, the method comprising:
advancing a delivery device to a target tissue in a urethra, a ureter, or a bladder in the patient, where the delivery device comprises a flexible member with an expandable device arranged thereon, the expandable device being configured to expand from a first compressed configuration to a second expanded configuration, and where at least a portion of the delivery device has a drug-eluting layer comprising one or more drugs;
positioning the expandable device at the target tissue with the delivery device; and
expanding the expandable device is from the first compressed configuration to the second expanded configuration for contact against the target tissue.

### Claim 22 (depends on 21)

The method of claim 21, wherein the one or more drugs comprises an anti-inflammatory drug, an anesthetic drug, a numbing drug, an antibiotic or antibacterial agent, an antifungal agent, an antiviral agent, an antiseptic, or a combination thereof.

### Claim 23 (depends on 21)

The method of claim 21, wherein the one or more drugs comprises an alpha-blocker, imipramine, an antispasmodic, a 5-alpha reductase inhibitor, or a combination thereof.

### Claim 24 (depends on 21)

The method of claim 21, wherein the one or more drugs comprises paclitaxel.

### Claim 25 (depends on 21)

The method of claim 21, wherein the flexible member comprises one or more drug-eluting layers.

### Claim 26 (depends on 21)

The method of claim 21, wherein the expandable device comprises one or more drug-eluting layers.

### Claim 27 (depends on 21)

The method of claim 21, wherein the one or more urinary conditions comprises at least one of urinary incontinence, urinary obstruction, benign prostatic hypertrophy, or a combination thereof.

### Claim 28 (depends on 21)

The method of claim 21, further comprising positioning the expandable device with the delivery device at a location between a wall of a urinary passageway and an obstruction.

### Claim 29 (depends on 28)

The method of claim 28, further comprising deploying the expandable device positioned with the delivery device to create a channel in the urinary passageway allowing urine to bypass the obstruction.

### Claim 30 (depends on 28)

The method of claim 28, further comprising deploying the expandable device positioned with the delivery device in the urinary passageway to prevent obstruction of the urinary passageway.

### Claim 31 (depends on 30)

The method of claim 30, wherein deploying the expandable device further comprises delivering the expandable device to at least one of the bladder and the urethra to prevent obstruction of the urinary passageway.

### Claim 32 (depends on 30)

The method of claim 30, wherein deploying the expandable device further comprises delivering the expandable device in the first compressed configuration to a location between a wall of the ureter and the obstruction, and wherein the method further comprises deploying the expandable device to create a channel in the urinary passageway allowing urine to bypass the obstruction.

### Claim 33 (depends on 28)

The method of claim 28, wherein expanding the expandable device from the first compressed configuration to the second expanded configuration dilates the target tissue near the delivery device.

### Claim 34 (depends on 21)

The method of claim 21, further comprising withdrawing the flexible member after positioning the expandable device, thereby leaving the expandable device positioned at the target tissue.

### Claim 35 (depends on 21)

The method of claim 21, wherein the expandable device comprises one or more biodegradable polymer filaments.

### Claim 36 (depends on 35)

The method of claim 35, wherein the one or more biodegradable polymer filaments are arranged to form a series of diamond shapes, and wherein a distal end of the expandable device and a proximal end of the expandable device are defined by each of the diamond shapes.

### Claim 37 (depends on 21)

The method of claim 21, wherein the expandable device comprises an expandable balloon.

### Claim 38 (depends on 37)

The method of claim 37, wherein the expandable balloon surrounds an outer surface of the flexible member.

### Claim 39 (depends on 37)

The method of claim 37, wherein the expandable balloon is detachable from the flexible member.

### Claim 40 (depends on 37)

The method of claim 37, wherein the expandable balloon in the second expanded configuration is configured to displace the target tissue in multiple directions.

### Claim 41 (depends on 37)

The method of claim 37, wherein the expandable balloon in the second expanded configuration is configured to dilate the target tissue near the expandable balloon.

### Claim 42 (depends on 21)

The method of claim 21, further comprising allowing release of one or more drugs from the drug-eluting layer to the target tissue

### Claim 43 (depends on 21)

The method of claim 21, wherein the flexible member comprises an atraumatic distal tip.
